Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-008424
Filing Date
2025-05-02
Accepted
2025-05-02 17:19:46
Documents
1
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4409
  Complete submission text file 0001641172-25-008424.txt   5878
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206, SUITE 302 BEDMINSTER NJ 07921
Business Address
Jabbour Jerome D (Reporting) CIK: 0001698838 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 25910031